Analyze Diet
Drug testing and analysis2022; 15(1); 42-46; doi: 10.1002/dta.3357

Synthesis and characterization of d5 -barbarin for use in barbarin-related research.

Abstract: Based on structural similarities and equine administration experiments, Barbarin, 5-phenyl-2-oxazolidinethione from Brassicaceae plants, is a possible source of equine urinary identifications of aminorex, (R,S)-5-phenyl-4,5-dihydro-1,3-oxazol-2-amine, an amphetamine-related US Drug Enforcement Administration (DEA) controlled substance considered illegal in sport horses. We now report the synthesis and certification of d -barbarin to facilitate research on the relationship between plant barbarin and such aminorex identifications. D -barbarin synthesis commenced with production of d -2-oxo-2-phenylacetaldehyde oxime (d -oxime) from d -acetophenone via butylnitrite in an ethoxide/ethanol solution. This d -oxime was then reduced with lithium aluminum hydride (LiAlH ) to produce the corresponding d -2-amino-1-phenylethan-1-ol (d -phenylethanolamine). Final ring closure of the d -phenylethanolamine was performed by the addition of carbon disulfide (CS ) with pyridine. The reaction product was purified by recrystallization and presented as a stable white crystalline powder. Proton NMR spectroscopy revealed a triplet at 5.88 ppm for one proton, a double doublet at 3.71 ppm for one proton, and double doublet at 4.11 ppm for one proton, confirming d -barbarin as the product. Further characterization by high resolution mass spectrometry supports the successful synthesis of d -barbarin. Purity of the recrystallized product was ascertained by High Performance Liquid Chromatography (HPLC) to be greater than 98%. Together, we have developed the synthesis and full characterization of d -barbarin for use as an internal standard in barbarin-related and equine forensic research.
Publication Date: 2022-08-23 PubMed ID: 35975356PubMed Central: PMC10087961DOI: 10.1002/dta.3357Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research discusses the successful synthesis and characterization of d5-barbarin, a substance that has structural similarities to aminorex, a controlled substance. This synthesized substance is intended to facilitate studies about the relationship between naturally occurring barbarin in plants and potentially misidentified aminorex in horse urine.

Synthesis of d5-barbarin

The process for creating d5-barbarin started with the following steps:

  • Producing d-2-oxo-2-phenylacetaldehyde oxime (d-oxime) from d-acetophenone. This procedure involved the use of butylnitrite in an ethoxide/ethanol solution.
  • This newly created d-oxime was then exposed to lithium aluminum hydride (LiAlH) to produce the corresponding d-2-amino-1-phenylethan-1-ol (d-phenylethanolamine).
  • The final ring closure of the d-phenylethanolamine was executed by adding carbon disulfide (CS) with pyridine to form the d5-barbarin.

Purification and Characterization of d5-barbarin

After formation, the synthesized d5-barbarin was clarified and embodied as a solid white crystalline powder, using these methods:

  • Recrystallization was used to purify the newly synthesized product.
  • Characterization of the recrystallised product was performed using Proton Nuclear Magnetic Resonance (NMR) spectroscopy, which detected specified proton patterns, validating d5-barbarin as the end product.
  • Further identification of the product was conducted using high resolution mass spectrometry, providing additional support for successful synthesis.
  • Lastly, purity testing was done through High Performance Liquid Chromatography (HPLC), confirming the d5-barbarin purity to be over 98%.

These consistent findings provide strong evidence for the successful and pure synthesis of d5-barbarin, which is expected to be invaluable in barbarin-related research and potentially in solving forensics cases in the equestrian world.

Cite This Article

APA
Kudrimoti S, Machin J, Arojojoye AS, Awuah SG, Eisenberg R, Fenger C, Maylin G, Lehner AF, Tobin T. (2022). Synthesis and characterization of d5 -barbarin for use in barbarin-related research. Drug Test Anal, 15(1), 42-46. https://doi.org/10.1002/dta.3357

Publication

ISSN: 1942-7611
NlmUniqueID: 101483449
Country: England
Language: English
Volume: 15
Issue: 1
Pages: 42-46

Researcher Affiliations

Kudrimoti, Sucheta
  • The Department of Veterinary Science and the Maxwell H. Gluck Equine Research Center and the Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, Kentucky, USA.
Machin, Jacob
  • The Department of Veterinary Science and the Maxwell H. Gluck Equine Research Center and the Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, Kentucky, USA.
Arojojoye, Adedamola S
  • Department of Chemistry, University of Kentucky, Lexington, Kentucky, USA.
Awuah, Samuel G
  • Department of Chemistry, University of Kentucky, Lexington, Kentucky, USA.
  • Center for Pharmaceutical Research and Innovation, College of Pharmacy and Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, Kentucky, USA.
Eisenberg, Rodney
  • Frontier BioPharm, LLC, Richmond, Kentucky, USA.
Fenger, Clara
  • Equine Integrated Medicine, Georgetown, Kentucky, USA.
Maylin, George
  • New York Drug Testing and Research Program, Ithaca, New York, USA.
Lehner, Andreas F
  • Veterinary Diagnostic Lab Section of Toxicology, Michigan State University, Lansing, Michigan, USA.
Tobin, Thomas
  • The Department of Veterinary Science and the Maxwell H. Gluck Equine Research Center and the Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, Kentucky, USA.

MeSH Terms

  • Animals
  • Horses
  • Aminorex
  • Protons
  • Oxazoles
  • Mass Spectrometry

Grant Funding

  • The Equine Health and Welfare Alliance, Inc, Versailles, Kentucky,
  • The National Horsemen's Benevolent and Protective Association and the Alabama, Arizona, Arkansas, Ontario, Canada; Charles Town, WV; Florida, Indiana, Iowa, Kentucky, Louisiana, Michigan, Minnesota, Nebraska, Ohio, Oklahoma, Oregon, Pennsylvania, Tampa Bay Downs, Florida, Texas, Washington State, and West Virginia Horsemen's Benevolent and Protective Associations
  • The United States Trotting Association, Columbus, OH
  • US Department of Agriculture
  • National Institute of Food and Agriculture

References

This article includes 14 references
  1. Hofmaier T, Luf A, Seddik A, Stockner T, Holy M, Freissmuth M, Ecker GF, Schmid R, Sitte HH, Kudlacek O. Aminorex, a metabolite of the cocaine adulterant levamisole, exerts amphetamine like actions at monoamine transporters.. Neurochem Int 2014 Jul;73(100):32-41.
  2. . ARCI Uniform Classification Guidelines for Foreign Substances January 2018. (V.13.4).
  3. Teale P, Biddle S. Possible Plant Sources of Aminorex and Potential markers of Their Ingestion in the Horse. Proceeds of the 22nd International Conference of Racing Analysists and Veterinarians Dubai, UAE p 140–148. 2018.
  4. Barker SA. The formation of aminorex in racehorses following levamisole administration. A quantitative and chiral analysis following synthetic aminorex or levamisole administration vs. aminorex-positive samples from the field: a preliminary report.. J Vet Pharmacol Ther 2009 Apr;32(2):160-6.
  5. Eiden C, Peyrière H, Diot C, Mathieu O. Prevalence of levamisole and aminorex in patients tested positive for cocaine in a French University Hospital.. Clin Toxicol (Phila) 2015;53(7):604-8.
    doi: 10.3109/15563650.2015.1054499pubmed: 26065363google scholar: lookup
  6. Gutierrez J, Eisenberg RL, Koval NJ, Armstrong ER, Tharappel J, Hughes CG, Tobin T. Pemoline and tetramisole 'positives' in english racehorses following levamisole administration.. Ir Vet J 2010 Aug 1;63(8):498.
    doi: 10.1186/2046-0481-63-8-498pmc: PMC4177197pubmed: 21777496google scholar: lookup
  7. Ho EN, Leung DK, Leung GN, Wan TS, Wong AS, Wong CH, Soma LR, Rudy JA, Uboh C, Sams R. Aminorex and rexamino as metabolites of levamisole in the horse.. Anal Chim Acta 2009 Apr 6;638(1):58-68.
    doi: 10.1016/j.aca.2009.02.033pubmed: 19298880google scholar: lookup
  8. Kjaer A, Gmelin R. IsoThiocyanates. XXVII. A new Isothyiocyanate glucoside (GlucoBarbarin) furnishing (−)‐5‐phenyl‐2‐oxazolidinethione upon enzymic hydrolysis. L Acta Chem Scand 1957;11:906‐907.
  9. Maylin G, Fenger C, Machin J, Kudrimoti S, Eisenberg R, Green J, Tobin T. Aminorex identified in horse urine following consumption of Barbarea vulgaris; a preliminary report.. Ir Vet J 2019;72:15.
    doi: 10.1186/s13620-019-0153-5pmc: PMC6929286pubmed: 31890155google scholar: lookup
  10. Norman JJ, Heggie RM, Larose JB. Oximes: 1.The synthesis of some substituted 2‐oximinoacetophenones Canadian. J Chem 1962;40(8):1547‐1553.
    doi: 10.1139/v62-233google scholar: lookup
  11. Walter CR Jr. Preparation of primary amines by reduction of oximes with lithium aluminum hydride and by the Leuckart reaction. J Am Chem Soc 1952;74(20):5185‐5187.
    doi: 10.1021/ja01140a060google scholar: lookup
  12. Santoro R, Warren R, Roberts G. Spontaneous formation of 4‐methyl‐5‐phenyloxazolidine‐2‐thione from phenylpropanolamine. J Chromatogr a 1976;117(2):375‐382.
  13. Machin J, Kudrimoti S, Eisenberg R. Synthesis, Characterization and Certification of Barbarin, a Possible Botanical Source of Aminorex Identifications. Submitted for presentation and publication, the Society of Forensic Toxicology (SOFT) Annual Meeting Oct 07–12, 2018. Minneapolis, Minnesota, p 92. 2018.
  14. Machin J, Childers T, Kudrimoti S, Eisenberg R, Fenger C, Hartmann P, Maylin G, Shults T, Tobin T. Synthesis and characterization of barbarin, a possible source of unexplained aminorex identifications in forensic science.. Drug Test Anal 2020 Oct;12(10):1477-1482.
    doi: 10.1002/dta.2883pubmed: 32567235google scholar: lookup

Citations

This article has been cited 0 times.